Targeting DNA topoisomerase II in cancer chemotherapy

2009/04/20 by John L. Nitiss · 10 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Lung Cancer Research Studies #Polyomavirus and related diseases

paper · doi:10.1038/nrc2607

crossref issued 2009/04/20 · crossref published 2009/04/20 · crossref published-online 2009/04/20 · openalex publication_date 2009/04/20 · crossref created 2009/04/20 · crossref published-print 2009/05/01 · crossref deposited 2023/05/19 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01 · crossref indexed 2026/08/04

Citations

• The Crystal Structure of Human Tyrosyl-DNA Phosphodiesterase, Tdp1

Cited by

• Recent developments in topoisomerase-targeted cancer chemotherapy
• Dexrazoxane for the treatment of chemotherapy-related side effects
• DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
• Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
• Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
• Topoisomerases as anticancer targets
• DNA topoisomerases as molecular targets for anticancer drugs
• Quinolones: Action and Resistance Updated
• Chemotherapy [wikipedia]
• Topoisomerase inhibitor [wikipedia]